Joshua Higa | Director, IR & Corporate Communications |
Emil Kakkis | Founder, President, CEO & Director |
Eric Crombez | Chief Medical Officer & EVP |
Aaron Olsen | SVP, Corporate Strategy & Finance |
Erik Harris | EVP & Chief Commercial Officer |
Gena Wang | Barclays Bank |
Liisa Bayko | Evercore ISI |
Maurice Raycroft | Jefferies |
Tommie Reerink | Goldman Sachs Group |
Joon Lee | Truist Securities |
Joori Park | Leerink Partners |
Kristen Kluska | Cantor Fitzgerald |
Dae Gon Ha | Stifel, Nicolaus & Company |
Yaron Werber | TD Cowen |
Nicole Gabreski | Piper Sandler & Co. |
Yigal Nochomovitz | Citigroup |
Good afternoon, and welcome to the Ultragenyx Second Quarter 2023 Financial Results Conference Call. [Operator Instructions]. It is now my pleasure to turn the call over to Joshua Higa, Vice President of Investor Relations.
Thank you.
We have issued a press release telling our financial results, which you can find on our website at ultragenyx.com.